首页 > 最新文献

Effective Pharmacotherapy最新文献

英文 中文
Menstrual Irregularities in Adolescents Caused by the COVID-19 Pandemic. Literature Review COVID-19大流行导致的青少年月经不规律文献综述
Pub Date : 2023-04-06 DOI: 10.33978/2307-3586-2023-19-7-34-39
L. Adamyan, YElyena Sibirskaya, I. Karachentsova, Y. Kirillova, M.A. Loshkareva, A. V. Krasivskaya
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 620 million diseases and 6.5 million deaths worldwide as of September 2022, according to World Health Organization (WHO). Today we know that, its effect on the respiratory and nervous systems. Vessels (endothelium), myocardium, kidneys, gastrointestinal tract and other organs are also affected. However, the impact of COVID-19 on the reproductive system and subsequent changes in the menstrual cycle insufficiently explored. The goal of the review is to study the impact of the coronavirus pandemic on the female reproductive system, in particular on the menstrual cycle of adolescent girls. The review includes clinical studies aimed at studying the impact of coronavirus infection (COVID-19) on reproductive function in adolescent girls. We searched for data in PubMed, Google Scholar and Cochrane Library search engines. Searching PubMed, Google Scholar, and Cochrane Library databases using keywords, 514 studies were found. Further, 42 articles were screened. During the selection, 30 articles were examined, selected by title and abstract of studies over the past few years. A full-text analysis of the selected studies was performed, as a result of which 11 studies were eligible for a qualitative synthesis
根据世界卫生组织(世卫组织)的数据,截至2022年9月,由严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2)引起的COVID-19大流行已在全球造成6.2亿多人患病,650万人死亡。今天我们知道,它对呼吸系统和神经系统的影响。血管(内皮)、心肌、肾脏、胃肠道等器官也受到影响。然而,COVID-19对生殖系统和随后的月经周期变化的影响尚未得到充分探讨。本次审查的目的是研究冠状病毒大流行对女性生殖系统的影响,特别是对少女月经周期的影响。该综述包括旨在研究冠状病毒感染(COVID-19)对青春期女孩生殖功能影响的临床研究。我们在PubMed, Google Scholar和Cochrane Library搜索引擎中搜索数据。使用关键词搜索PubMed、Google Scholar和Cochrane Library数据库,发现了514项研究。此外,筛选了42篇文章。在评选过程中,考察了30篇文章,根据近年来的研究题目和摘要进行了筛选。对选定的研究进行了全文分析,结果有11项研究有资格进行定性综合
{"title":"Menstrual Irregularities in Adolescents Caused by the COVID-19 Pandemic. Literature Review","authors":"L. Adamyan, YElyena Sibirskaya, I. Karachentsova, Y. Kirillova, M.A. Loshkareva, A. V. Krasivskaya","doi":"10.33978/2307-3586-2023-19-7-34-39","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-34-39","url":null,"abstract":"The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused more than 620 million diseases and 6.5 million deaths worldwide as of September 2022, according to World Health Organization (WHO). Today we know that, its effect on the respiratory and nervous systems. Vessels (endothelium), myocardium, kidneys, gastrointestinal tract and other organs are also affected. However, the impact of COVID-19 on the reproductive system and subsequent changes in the menstrual cycle insufficiently explored. The goal of the review is to study the impact of the coronavirus pandemic on the female reproductive system, in particular on the menstrual cycle of adolescent girls. The review includes clinical studies aimed at studying the impact of coronavirus infection (COVID-19) on reproductive function in adolescent girls. We searched for data in PubMed, Google Scholar and Cochrane Library search engines. Searching PubMed, Google Scholar, and Cochrane Library databases using keywords, 514 studies were found. Further, 42 articles were screened. During the selection, 30 articles were examined, selected by title and abstract of studies over the past few years. A full-text analysis of the selected studies was performed, as a result of which 11 studies were eligible for a qualitative synthesis","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88888249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neoplasms of the Pelvic Cavity in Pediatrics. Features of Differential Diagnosis 儿科盆腔肿瘤。鉴别诊断的特点
Pub Date : 2023-04-06 DOI: 10.33978/2307-3586-2023-19-7-54-58
L. Adamyan, YElyena Sibirskaya, I. Karachentsova, I. N. Skapenkov, D. S. Avetisyan, Ye.I. Krylova, Ye.D. Nakhapetyan
The frequency of detection of stromal gastrointestinal tumors in children and adolescents is about 0.4% of the total number of diagnosed GISTs. These tumors can occur throughout the gastrointestinal tract. During the instrumental research, misinterpretation of tumor origin is possible. For this reason, the consistent use of a variety of non-invasive diagnostic methods is extremely important in the preoperative period. We present a case report of a rare GIST detection in pediatrics, which at the stage of noninvasive diagnostic studies was determined as a pelvic tumor. It was possible to accurately determine its origin only after diagnostic laparoscopy. We also provide a description of instrumental and laboratory research methods for the differential diagnosis of the abdominal and pelvic cavities neoplasms
儿童和青少年间质胃肠道肿瘤的检出率约占诊断出的胃肠道间质瘤总数的0.4%。这些肿瘤可发生于整个胃肠道。在仪器研究中,对肿瘤起源的误解是可能的。因此,在术前持续使用多种无创诊断方法是非常重要的。我们提出一个罕见的儿科GIST检测的病例报告,在非侵入性诊断研究的阶段被确定为盆腔肿瘤。只有在诊断性腹腔镜检查后才能准确地确定其来源。我们也提供仪器和实验室研究方法的描述,以鉴别诊断腹腔和盆腔肿瘤
{"title":"Neoplasms of the Pelvic Cavity in Pediatrics. Features of Differential Diagnosis","authors":"L. Adamyan, YElyena Sibirskaya, I. Karachentsova, I. N. Skapenkov, D. S. Avetisyan, Ye.I. Krylova, Ye.D. Nakhapetyan","doi":"10.33978/2307-3586-2023-19-7-54-58","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-54-58","url":null,"abstract":"The frequency of detection of stromal gastrointestinal tumors in children and adolescents is about 0.4% of the total number of diagnosed GISTs. These tumors can occur throughout the gastrointestinal tract. During the instrumental research, misinterpretation of tumor origin is possible. For this reason, the consistent use of a variety of non-invasive diagnostic methods is extremely important in the preoperative period. We present a case report of a rare GIST detection in pediatrics, which at the stage of noninvasive diagnostic studies was determined as a pelvic tumor. It was possible to accurately determine its origin only after diagnostic laparoscopy. We also provide a description of instrumental and laboratory research methods for the differential diagnosis of the abdominal and pelvic cavities neoplasms","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"54 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73571326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Giant Ovarian Tumor in a 16-Year-Old Girl 16岁女孩的巨大卵巢肿瘤
Pub Date : 2023-04-06 DOI: 10.33978/2307-3586-2023-19-7-64-69
YElyena Sibirskaya, I. Karachentsova, S. Sharkov, Y. Kirillova, Ye.V. Pavlova
Ovarian tumors are an important and urgent problem of modern gynecology. This is due to the difficulties in diagnosing neoplasms due to the absence of characteristic complaints and frequent asymptomatic course. Pediatric surgeons, pediatric gynecologists should conduct differential diagnostics between ovarian tumors and tumors of the abdominal cavity and retroperitoneal space in order to timely diagnose and treat neoplasms and prevent possible medical error. The article presents an indicative clinical case of the occurrence of giant mucinous ovarian cystadenoma in a teenage girl requiring differential diagnosis with formations of a different localization. Patient F., 16 years old, was admitted to the hospital in the direction of one of the regions of the Russian Federation. The reason for the patient's treatment to a gynecologist at the place of residence was pain in the lower abdomen for a month and an increase in the size of the abdomen. The patient was sent to the hospital to clarify the diagnosis and further treatment. Radical surgical treatment was performed: removal of the cyst of the left ovary using video endoscopic technologies
卵巢肿瘤是现代妇科重要而紧迫的问题。这是由于缺乏特征性的主诉和频繁的无症状过程,使肿瘤难以诊断。小儿外科医生、儿科妇科医生应对卵巢肿瘤与腹腔及腹膜后间隙肿瘤进行鉴别诊断,及时诊断和治疗肿瘤,防止可能出现的医疗差错。文章提出了一个指示性的临床病例发生巨大的粘液性卵巢囊腺瘤在一个十几岁的女孩需要鉴别诊断与不同的定位形成。病人F, 16岁,被送往俄罗斯联邦一个地区方向的医院。患者到居住地妇科就诊的原因是下腹疼痛一个月,腹部增大。患者被送往医院明确诊断并进一步治疗。进行根治性手术治疗:采用视频内镜技术切除左卵巢囊肿
{"title":"A Giant Ovarian Tumor in a 16-Year-Old Girl","authors":"YElyena Sibirskaya, I. Karachentsova, S. Sharkov, Y. Kirillova, Ye.V. Pavlova","doi":"10.33978/2307-3586-2023-19-7-64-69","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-64-69","url":null,"abstract":"Ovarian tumors are an important and urgent problem of modern gynecology. This is due to the difficulties in diagnosing neoplasms due to the absence of characteristic complaints and frequent asymptomatic course. Pediatric surgeons, pediatric gynecologists should conduct differential diagnostics between ovarian tumors and tumors of the abdominal cavity and retroperitoneal space in order to timely diagnose and treat neoplasms and prevent possible medical error. The article presents an indicative clinical case of the occurrence of giant mucinous ovarian cystadenoma in a teenage girl requiring differential diagnosis with formations of a different localization. Patient F., 16 years old, was admitted to the hospital in the direction of one of the regions of the Russian Federation. The reason for the patient's treatment to a gynecologist at the place of residence was pain in the lower abdomen for a month and an increase in the size of the abdomen. The patient was sent to the hospital to clarify the diagnosis and further treatment. Radical surgical treatment was performed: removal of the cyst of the left ovary using video endoscopic technologies","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85384539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential Diagnosis of Cervical Cancer in Perimenopause 围绝经期宫颈癌的鉴别诊断
Pub Date : 2023-04-06 DOI: 10.33978/2307-3586-2023-19-7-73-75
YElyena Sibirskaya, P. O. Nikiforova
Perimenopause is a period in a woman’s life characterized by estrogen deficiency, leading to atrophic changes in the reproductive system, which are directly correlated with the incidence of the cervical cancer. Using the example of this case report, we would like to demonstrate that a competent examination helps to verify the diagnosis, before using laboratory and instrumental diagnostic methods
围绝经期是女性一生中以雌激素缺乏为特征的一个时期,导致生殖系统的萎缩变化,这与宫颈癌的发病率直接相关。使用本病例报告的例子,我们想证明,在使用实验室和仪器诊断方法之前,合格的检查有助于验证诊断
{"title":"Differential Diagnosis of Cervical Cancer in Perimenopause","authors":"YElyena Sibirskaya, P. O. Nikiforova","doi":"10.33978/2307-3586-2023-19-7-73-75","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-73-75","url":null,"abstract":"Perimenopause is a period in a woman’s life characterized by estrogen deficiency, leading to atrophic changes in the reproductive system, which are directly correlated with the incidence of the cervical cancer. Using the example of this case report, we would like to demonstrate that a competent examination helps to verify the diagnosis, before using laboratory and instrumental diagnostic methods","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83397023","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Surgical Correction of Pelvic Organ Prolapse Association with Total Uterine Prolapse 盆腔器官脱垂伴全子宫脱垂的手术矫正
Pub Date : 2023-04-06 DOI: 10.33978/2307-3586-2023-19-7-70-72
Ye.V. Sibirskaya, I. Karachentsova, K. S. Baranov, Y. Kirillova, P. O. Nikiforova
Total prolapse of the uterus is a common pathology in older women who have given birth. To date, there is no single ‘gold standard’ in the surgical management of women with total uterine prolapse. Using the example of this case report, we would like to demonstrate that the operation of choice should be considered – vaginal extirpation of the uterus without appendages. This is due to the lower frequency of intraoperative complications and the peculiarities of the course of the postoperative period, as well as early activation and rehabilitation
子宫完全脱垂是生育过的高龄妇女的常见病理。迄今为止,没有一个单一的“金标准”,在手术管理的妇女全子宫脱垂。用这个病例报告的例子,我们想证明手术的选择应该被考虑-阴道切除子宫没有附属物。这是由于术中并发症的发生率较低,术后过程的特殊性,以及早期激活和康复
{"title":"Surgical Correction of Pelvic Organ Prolapse Association with Total Uterine Prolapse","authors":"Ye.V. Sibirskaya, I. Karachentsova, K. S. Baranov, Y. Kirillova, P. O. Nikiforova","doi":"10.33978/2307-3586-2023-19-7-70-72","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-70-72","url":null,"abstract":"Total prolapse of the uterus is a common pathology in older women who have given birth. To date, there is no single ‘gold standard’ in the surgical management of women with total uterine prolapse. Using the example of this case report, we would like to demonstrate that the operation of choice should be considered – vaginal extirpation of the uterus without appendages. This is due to the lower frequency of intraoperative complications and the peculiarities of the course of the postoperative period, as well as early activation and rehabilitation","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75616104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Giant Juvenile Fibroadenoma of the Breast in a 13-Year-Old Girl: a Case Report. Diagnostic Features 13岁女童巨大幼年乳腺纤维腺瘤1例报告。诊断功能
Pub Date : 2023-04-06 DOI: 10.33978/2307-3586-2023-19-7-59-63
YElyena Sibirskaya, I. Karachentsova, I.A. Melenchuk, D.Yu. Gripas, S.K. Ukolova
The article describes a clinical case of giant fibroadenoma in a 13-year-old girl, whose size was 20 cm, as well as a brief review of the scientific literature on benign neoplasms of the mammary glands in young patients. Giant fibroadenomas account for 0.5 to 2% of all fibroadenomas. In children and adolescents, ultrasound of the mammary glands is the main method of diagnosing fibroadenoma. Fibroadenoma needs to be differentiated from a phylloid tumor, which is clinically no different from fibroadenoma, but at the same time it has a high risk of malignancy. To make a final diagnosis, a puncture fine needle aspiration biopsy is additionally perform
本文描述了一个13岁女孩的巨大纤维腺瘤的临床病例,其大小为20cm,并简要回顾了年轻患者乳腺良性肿瘤的科学文献。巨大纤维腺瘤占所有纤维腺瘤的0.5 - 2%。在儿童和青少年中,乳腺超声是诊断纤维腺瘤的主要方法。纤维腺瘤需要与叶状瘤鉴别,叶状瘤在临床上与纤维腺瘤没有区别,但同时具有较高的恶性风险。为了做出最终诊断,还要进行穿刺细针穿刺活检
{"title":"Giant Juvenile Fibroadenoma of the Breast in a 13-Year-Old Girl: a Case Report. Diagnostic Features","authors":"YElyena Sibirskaya, I. Karachentsova, I.A. Melenchuk, D.Yu. Gripas, S.K. Ukolova","doi":"10.33978/2307-3586-2023-19-7-59-63","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-59-63","url":null,"abstract":"The article describes a clinical case of giant fibroadenoma in a 13-year-old girl, whose size was 20 cm, as well as a brief review of the scientific literature on benign neoplasms of the mammary glands in young patients. Giant fibroadenomas account for 0.5 to 2% of all fibroadenomas. In children and adolescents, ultrasound of the mammary glands is the main method of diagnosing fibroadenoma. Fibroadenoma needs to be differentiated from a phylloid tumor, which is clinically no different from fibroadenoma, but at the same time it has a high risk of malignancy. To make a final diagnosis, a puncture fine needle aspiration biopsy is additionally perform","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82967065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reproductive Aspects of the Problem of Conservative Surgical Treatment of Endometrioid Ovarian Cysts 子宫内膜样卵巢囊肿保守手术治疗的生殖方面问题
Pub Date : 2023-04-04 DOI: 10.33978/2307-3586-2023-19-7-18-23
K. V. Krasnopolskaya, I.Yu. Yershova, A. Samoylova
The aim is to clarify the timing of recurrence of endometriomas removed and the dependence of the ovarian reserve status on the number of ovarian resections performed, as well as to assess the awareness of patients about the impact of surgical treatment of endometrioid ovarian cysts (EOC) on reproductive function and therapeutic effectiveness of in vitro fertilization (IVF) technology. Material and methods. In 93 infertile patients with EOC and values of anti-muller hormone (AMH) < 1.2 ng/ml, the dependence of the degree of reduction of this hormone on the number of operations performed with relapses of endometrioma was analyzed. Using standard research methods in the same patients, the prevalence of infertility factors identified in the International Classification of Diseases of the 10th revision was studied in parallel, and women's awareness of the impact of surgical treatment of EOC on reproductive potential was clarified. Results. Other forms of endometriosis were found in 71% of women with EOC, and the observed infertility, which necessitated the appointment of IVF, was mainly associated with confirmed male and tubal factors. Among the patients operated on for EOC with a reduced level of AMH, the majority underwent repeated ovarian resections due to relapses of endometriomas that occurred within two and a half years after their removal. The degree of decrease in the level of AMH was directly dependent on the number of operations performed. During surgical treatment of EOC, only 7.5% of patients received relevant information about their frequent recurrence and possible consequences for the reproductive function of ovarian resection performed (especially multiple). Conclusions. Frequent recurrence of EOC, which forces repeated resections of the ovaries, is an obvious factor that, due to the reduction of the ovarian reserve, prevents the successful use of IVF technology with its own oocytes in situations where this method of infertility treatment is in demand. When planning the removal of EOC in women of reproductive age, surgeons should necessarily refer patients to reproductologists for advice on issues related to the implementation of reproductive plans both in the near and long term
目的是明确切除子宫内膜异位瘤的复发时间和卵巢储备状态与卵巢切除次数的依赖关系,评估患者对手术治疗子宫内膜样卵巢囊肿(EOC)对生殖功能的影响和体外受精(IVF)技术治疗效果的认识。材料和方法。分析93例抗穆勒激素(AMH)值< 1.2 ng/ml的EOC不孕患者,该激素降低程度与子宫内膜异位瘤复发手术次数的依赖关系。采用标准的研究方法,在同一患者中平行研究《国际疾病分类第十版》中确定的不孕因素的流行情况,明确女性对EOC手术治疗对生殖潜能影响的认识。结果。在71%的EOC女性中发现了其他形式的子宫内膜异位症,并且观察到的不孕症(需要试管受精)主要与确认的男性和输卵管因素相关。在AMH水平降低的EOC手术患者中,由于子宫内膜异位瘤在切除后两年半内复发,大多数患者进行了多次卵巢切除术。AMH水平的下降程度与手术次数直接相关。在EOC的手术治疗过程中,只有7.5%的患者了解到他们的频繁复发以及卵巢切除术(尤其是多卵巢切除术)可能对生殖功能造成的影响。结论。EOC的频繁复发,迫使反复切除卵巢,这是一个明显的因素,由于卵巢储备的减少,在需要这种不孕症治疗方法的情况下,阻碍了使用其自身卵母细胞的体外受精技术的成功使用。当计划在育龄妇女中切除卵巢囊肿时,外科医生必须将患者转介给生殖专家,就近期和长期实施生殖计划的相关问题征求意见
{"title":"Reproductive Aspects of the Problem of Conservative Surgical Treatment of Endometrioid Ovarian Cysts","authors":"K. V. Krasnopolskaya, I.Yu. Yershova, A. Samoylova","doi":"10.33978/2307-3586-2023-19-7-18-23","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-18-23","url":null,"abstract":"The aim is to clarify the timing of recurrence of endometriomas removed and the dependence of the ovarian reserve status on the number of ovarian resections performed, as well as to assess the awareness of patients about the impact of surgical treatment of endometrioid ovarian cysts (EOC) on reproductive function and therapeutic effectiveness of in vitro fertilization (IVF) technology. Material and methods. In 93 infertile patients with EOC and values of anti-muller hormone (AMH) < 1.2 ng/ml, the dependence of the degree of reduction of this hormone on the number of operations performed with relapses of endometrioma was analyzed. Using standard research methods in the same patients, the prevalence of infertility factors identified in the International Classification of Diseases of the 10th revision was studied in parallel, and women's awareness of the impact of surgical treatment of EOC on reproductive potential was clarified. Results. Other forms of endometriosis were found in 71% of women with EOC, and the observed infertility, which necessitated the appointment of IVF, was mainly associated with confirmed male and tubal factors. Among the patients operated on for EOC with a reduced level of AMH, the majority underwent repeated ovarian resections due to relapses of endometriomas that occurred within two and a half years after their removal. The degree of decrease in the level of AMH was directly dependent on the number of operations performed. During surgical treatment of EOC, only 7.5% of patients received relevant information about their frequent recurrence and possible consequences for the reproductive function of ovarian resection performed (especially multiple). Conclusions. Frequent recurrence of EOC, which forces repeated resections of the ovaries, is an obvious factor that, due to the reduction of the ovarian reserve, prevents the successful use of IVF technology with its own oocytes in situations where this method of infertility treatment is in demand. When planning the removal of EOC in women of reproductive age, surgeons should necessarily refer patients to reproductologists for advice on issues related to the implementation of reproductive plans both in the near and long term","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"655 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76839572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of Terlipressin (Remestyp) in Performing Myomectomy During Cesarean Section 特立加压素在剖宫产术子宫肌瘤切除术中的应用效果
Pub Date : 2023-04-04 DOI: 10.33978/2307-3586-2023-19-7-14-16
N. Kuneshko, I.Kh. Tsaroeva, Yu.O. Kosmakova
A study was conducted on the effectiveness of terlipressin during myomectomy during cesarean section in pregnant women with uterine fibroids. The drug has demonstrated high efficacy, significantly reducing the level of intraoperative blood loss and shortening the duration of surgery.
研究特利加压素在子宫肌瘤孕妇剖宫产术中肌瘤切除术的有效性。该药疗效高,可显著降低术中出血量,缩短手术时间。
{"title":"The Effectiveness of Terlipressin (Remestyp) in Performing Myomectomy During Cesarean Section","authors":"N. Kuneshko, I.Kh. Tsaroeva, Yu.O. Kosmakova","doi":"10.33978/2307-3586-2023-19-7-14-16","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-14-16","url":null,"abstract":"A study was conducted on the effectiveness of terlipressin during myomectomy during cesarean section in pregnant women with uterine fibroids. The drug has demonstrated high efficacy, significantly reducing the level of intraoperative blood loss and shortening the duration of surgery.","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87631663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effectiveness of the Dosed Cream Acilact Duo in Patients with Bacterial Vaginosis 剂量性乳膏Acilact Duo治疗细菌性阴道病的疗效观察
Pub Date : 2023-04-04 DOI: 10.33978/2307-3586-2023-19-7-6-12
Ye.V. Tikhomirova, Vysakh Balan, Ye.V. Kruchinina, P. Balan, S. Orlova, Y. Titchenko, Ye.A. Levkovich, V. Yatsyuk
Bacterial vaginosis is a clinical condition in which the normal vaginal microflora, predominantly lactobacilli, is replaced by other microorganisms, mainly anaerobes. The goal of treating bacterial vaginosis is to restore the normal microflora of the vagina, to delay the growth of microorganisms that are not characteristic of this vaginal microcenosis. The purpose of the study was to evaluate the effectiveness of various methods of combined two-stage treatment of bacterial vaginosis in women of reproductive age. Material and methods. The study included 50 patients aged 18 to 45 years (mean age 29.6 ± 4.5 years) with bacterial vaginosis. The first group consisted of 25 patients who received Clindamycin 2% cream for 7 days, dose vaginally at night. For the second stage of therapy in this 1 group, acidophilus bacteria + vitamin-mineral-protein-peptide complex Superlimfly (Acylact Duo) were used, suppository time per day at night intravaginally for 10 days. The second group consisted of 25 patients who received Clindacimin cream for 7 days, dose vaginally at night. For the second stage of therapy, a preparation containing a lyophilized culture of lactobacilli L. casei rhamnosus Doderleini was used, at least 1 × 108 CFU, capsule in the vagina at night for 14 days. Results. The effectiveness of BV therapy was 49% (n = 46). The duration of remission was 24.1 ± 2.1 days (n = 24) in the group of women receiving adjuvant therapy with Acilact Duo dosed cream, and 19.9 ± 2 3. days (n = 22) in the comparison group. In all patients, the average vaginal pH before therapy was 5.5 ± 0.4. In group1 participants, after therapy, the pH was 4.54 ± 0.143 , in group 2 patients, the average vaginal pH was 4.976 ± 0.241. Among the patients of both groups, vaginal dysbiosis of varying severity was detected before treatment (normocenosis was not detected). After therapy, in patients of group, normocenosis of the vagina was achieved in 88% (22/25), in participants of group 2, normocenosis was noted in 72% (18/25). At visit (in 45 days) in women of the group 1 84% (21/25), in the participants of the group 2 – normocenosis was noted in 64% (16/25). Conclusions. Acidophilic bacteria + vitamin-mineral-protein-peptide complex Superlymfly (in which dosed Acylact Duo) quickly restores the optimal acidity of the vagina (pH value) and promotes the growth of the number of beneficial lactobacilli, as a result of which it creates an optimal and natural microflora that prevents the appearance of dysbiosis in patients of reproductive age
细菌性阴道病是一种临床状况,其中正常的阴道微生物群,主要是乳酸菌,被其他微生物,主要是厌氧菌所取代。治疗细菌性阴道病的目的是恢复阴道的正常菌群,以延缓微生物的生长,不是这种阴道微囊病的特征。本研究的目的是评价两期联合治疗育龄妇女细菌性阴道病的各种方法的有效性。材料和方法。本研究纳入50例18 ~ 45岁(平均29.6±4.5岁)细菌性阴道病患者。第一组25例患者接受2%克林霉素乳膏7天,夜间阴道给药。第二期治疗采用嗜酸杆菌+维生素-矿物质-蛋白-肽复合物Superlimfly (Acylact Duo),每天夜间经阴道灌栓一次,持续10天。第二组25例患者连续7天服用克林西敏乳膏,夜间经阴道给药。在第二阶段治疗中,使用含有干酪乳杆菌鼠李糖杜氏乳杆菌冻干培养物的制剂,至少1 × 108 CFU胶囊,每晚阴道内服用14天。结果。BV治疗的有效率为49% (n = 46)。接受Acilact Duo软膏辅助治疗组缓解时间为24.1±2.1天(n = 24),而接受Acilact Duo软膏辅助治疗组缓解时间为19.9±2.3天。(n = 22)。所有患者治疗前阴道pH平均值为5.5±0.4。治疗后,组1患者阴道pH值为4.54±0.143,组2患者阴道pH值平均为4.976±0.241。两组患者均在治疗前发现不同程度的阴道生态失调(未发现正常增生)。治疗后,1组患者中88%(22/25)的患者阴道恢复正常,2组患者中72%(18/25)的患者阴道恢复正常。在就诊时(45天内),组中84%(21/25)的女性,在2组参与者中-正常生育的比例为64%(16/25)。结论。嗜酸菌+维生素-矿物质-蛋白-肽复合物Superlymfly(其中添加Acylact Duo)迅速恢复阴道的最佳酸度(pH值),促进有益乳酸菌数量的增长,因此它创造了一个最佳和自然的微生物群,防止育龄患者出现生态失调
{"title":"The Effectiveness of the Dosed Cream Acilact Duo in Patients with Bacterial Vaginosis","authors":"Ye.V. Tikhomirova, Vysakh Balan, Ye.V. Kruchinina, P. Balan, S. Orlova, Y. Titchenko, Ye.A. Levkovich, V. Yatsyuk","doi":"10.33978/2307-3586-2023-19-7-6-12","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-7-6-12","url":null,"abstract":"Bacterial vaginosis is a clinical condition in which the normal vaginal microflora, predominantly lactobacilli, is replaced by other microorganisms, mainly anaerobes. The goal of treating bacterial vaginosis is to restore the normal microflora of the vagina, to delay the growth of microorganisms that are not characteristic of this vaginal microcenosis. The purpose of the study was to evaluate the effectiveness of various methods of combined two-stage treatment of bacterial vaginosis in women of reproductive age. Material and methods. The study included 50 patients aged 18 to 45 years (mean age 29.6 ± 4.5 years) with bacterial vaginosis. The first group consisted of 25 patients who received Clindamycin 2% cream for 7 days, dose vaginally at night. For the second stage of therapy in this 1 group, acidophilus bacteria + vitamin-mineral-protein-peptide complex Superlimfly (Acylact Duo) were used, suppository time per day at night intravaginally for 10 days. The second group consisted of 25 patients who received Clindacimin cream for 7 days, dose vaginally at night. For the second stage of therapy, a preparation containing a lyophilized culture of lactobacilli L. casei rhamnosus Doderleini was used, at least 1 × 108 CFU, capsule in the vagina at night for 14 days. Results. The effectiveness of BV therapy was 49% (n = 46). The duration of remission was 24.1 ± 2.1 days (n = 24) in the group of women receiving adjuvant therapy with Acilact Duo dosed cream, and 19.9 ± 2 3. days (n = 22) in the comparison group. In all patients, the average vaginal pH before therapy was 5.5 ± 0.4. In group1 participants, after therapy, the pH was 4.54 ± 0.143 , in group 2 patients, the average vaginal pH was 4.976 ± 0.241. Among the patients of both groups, vaginal dysbiosis of varying severity was detected before treatment (normocenosis was not detected). After therapy, in patients of group, normocenosis of the vagina was achieved in 88% (22/25), in participants of group 2, normocenosis was noted in 72% (18/25). At visit (in 45 days) in women of the group 1 84% (21/25), in the participants of the group 2 – normocenosis was noted in 64% (16/25). Conclusions. Acidophilic bacteria + vitamin-mineral-protein-peptide complex Superlymfly (in which dosed Acylact Duo) quickly restores the optimal acidity of the vagina (pH value) and promotes the growth of the number of beneficial lactobacilli, as a result of which it creates an optimal and natural microflora that prevents the appearance of dysbiosis in patients of reproductive age","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"5 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87968239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Control of Major Cardiovascular Risk Factors in Patients with Type 2 Diabetes and Diabetic Foot Syndrome 2型糖尿病和糖尿病足综合征患者主要心血管危险因素的控制
Pub Date : 2023-03-30 DOI: 10.33978/2307-3586-2023-19-1-26-31
I.I. Teltevskaia, S. V. Ivanova, E. Yushchuk, A. Mkrtumyan, I. V. Melehina, E. Trush
Cardiovascular disease (CVD) is the main cause of death in patients with diabetes mellitus (DM). Cardiovascular risk in patients with type 2 diabetes is 2–4 times higher, and CVD occurs 15 years earlier than in people without diabetes. Timely detection and effective control of risk factors are of decisive importance for the prevention of complications of type 2 diabetes. The aim of the study: to identify cardiovascular risk factors and analyze the effectiveness of their control in patients with type 2 DM and diabetic foot syndrome (DFS). Material and methods. 80 patients with type 2 diabetes without associated CVD. Mean age 64.6 ± 9.2 years. The duration of type 2 diabetes was 10.0 (4.0; 15.0) years. Conducted a clinical examination, laboratory (clinical and biochemical blood tests) and instrumental (electrocardiography, ultrasound of the brachiocephalic arteries and arteries of the lower extremities, echocardiography, volumetric sphygmography) studies. Results. The frequency of detection of hypertension was 98.8%, dyslipidemia 91.0%. Target values of blood pressure (BP) were noted in 32.0%, and target values of low-density lipoprotein cholesterol (LDL-C) in 26.0% of the examined. 80.0% of patients received antihypertensive therapy, and 39.7% of patients received lipid-lowering therapy. Metformin was the most commonly prescribed oral hypoglycemic drug in the structure of drug therapy for type 2 diabetes. Insulin was significantly more frequently prescribed to patients with DFS. The target level of glycated hemoglobin (HbA1c) was observed in 55.0% of patients. Patients with DFS had significantly higher systolic and pulse BP, and reached the target BP values three times less often. Conclusion. Patients with type 2 diabetes are characterized by insufficiently effective control of glycemia and major cardiovascular risk factors. Thus, the target HbA1c levels were noted in every second patient, the target BP level in every third patient, and the target values of LDL-C only in every fourth patient.
心血管疾病(CVD)是糖尿病(DM)患者死亡的主要原因。2型糖尿病患者的心血管风险高出2 - 4倍,心血管疾病的发生时间比非糖尿病患者早15年。及时发现并有效控制危险因素对预防2型糖尿病并发症具有决定性意义。本研究的目的是:确定2型糖尿病合并糖尿病足综合征(DFS)患者的心血管危险因素并分析其控制效果。材料和方法。80例2型糖尿病患者无相关心血管疾病。平均年龄64.6±9.2岁。2型糖尿病病程为10.0 (4.0;15.0)年。进行了临床检查、实验室(临床和生化血液检查)和仪器(心电图、头臂动脉和下肢动脉超声、超声心动图、容积血压计)研究。结果。高血压检出率为98.8%,血脂异常检出率为91.0%。血压(BP)目标值为32.0%,低密度脂蛋白胆固醇(LDL-C)目标值为26.0%。80.0%的患者接受降压治疗,39.7%的患者接受降脂治疗。二甲双胍是2型糖尿病药物治疗结构中最常用的口服降糖药。DFS患者使用胰岛素的频率明显更高。55.0%的患者糖化血红蛋白(HbA1c)达到目标水平。DFS患者的收缩压和脉压明显升高,达到目标血压的次数减少了3倍。结论。2型糖尿病患者的特点是血糖和主要心血管危险因素控制不够有效。因此,每2例患者记录目标HbA1c水平,每3例患者记录目标BP水平,每4例患者仅记录LDL-C目标值。
{"title":"Control of Major Cardiovascular Risk Factors in Patients with Type 2 Diabetes and Diabetic Foot Syndrome","authors":"I.I. Teltevskaia, S. V. Ivanova, E. Yushchuk, A. Mkrtumyan, I. V. Melehina, E. Trush","doi":"10.33978/2307-3586-2023-19-1-26-31","DOIUrl":"https://doi.org/10.33978/2307-3586-2023-19-1-26-31","url":null,"abstract":"Cardiovascular disease (CVD) is the main cause of death in patients with diabetes mellitus (DM). Cardiovascular risk in patients with type 2 diabetes is 2–4 times higher, and CVD occurs 15 years earlier than in people without diabetes. Timely detection and effective control of risk factors are of decisive importance for the prevention of complications of type 2 diabetes. The aim of the study: to identify cardiovascular risk factors and analyze the effectiveness of their control in patients with type 2 DM and diabetic foot syndrome (DFS). Material and methods. 80 patients with type 2 diabetes without associated CVD. Mean age 64.6 ± 9.2 years. The duration of type 2 diabetes was 10.0 (4.0; 15.0) years. Conducted a clinical examination, laboratory (clinical and biochemical blood tests) and instrumental (electrocardiography, ultrasound of the brachiocephalic arteries and arteries of the lower extremities, echocardiography, volumetric sphygmography) studies. Results. The frequency of detection of hypertension was 98.8%, dyslipidemia 91.0%. Target values of blood pressure (BP) were noted in 32.0%, and target values of low-density lipoprotein cholesterol (LDL-C) in 26.0% of the examined. 80.0% of patients received antihypertensive therapy, and 39.7% of patients received lipid-lowering therapy. Metformin was the most commonly prescribed oral hypoglycemic drug in the structure of drug therapy for type 2 diabetes. Insulin was significantly more frequently prescribed to patients with DFS. The target level of glycated hemoglobin (HbA1c) was observed in 55.0% of patients. Patients with DFS had significantly higher systolic and pulse BP, and reached the target BP values three times less often. Conclusion. Patients with type 2 diabetes are characterized by insufficiently effective control of glycemia and major cardiovascular risk factors. Thus, the target HbA1c levels were noted in every second patient, the target BP level in every third patient, and the target values of LDL-C only in every fourth patient.","PeriodicalId":11400,"journal":{"name":"Effective Pharmacotherapy","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86142393","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Effective Pharmacotherapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1